Last reviewed · How we verify

NCT03264261

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Recruiting now NA Last updated 3 June 2025
What this trial tests

NA trial testing robotic training in Stroke in 36 participants. Currently enrolling.

Timeline
14 August 2017
Primary endpoint
30 July 2025
30 December 2025

Quick facts

Lead sponsorShirley Ryan AbilityLab
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment36
Start date14 August 2017
Primary completion30 July 2025
Estimated completion30 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Shirley Ryan AbilityLab — full company profile →

Who can join

Adults 21 to 75, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Electromechanical-assisted training for walking after stroke.
    Mehrholz J, Thomas S, Kugler J, Pohl M, et al · · 2020 · cited 146× · PMID 33091160 · DOI 10.1002/14651858.cd006185.pub5

Verify or expand the search:

Other trials of robotic training

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Shirley Ryan AbilityLab trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03264261.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing